<DOC>
	<DOCNO>NCT00107016</DOCNO>
	<brief_summary>The purpose study examine effect combination everolimus letrozole compare placebo letrozole pre-surgical therapy patient newly diagnose estrogen receptor positive breast cancer .</brief_summary>
	<brief_title>Everolimus Letrozole Preoperative Therapy Primary Breast Cancer Post-menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Histologicallyconfirmed diagnosis invasive breast cancer , previously untreated Patients must postmenopausal Candidates mastectomy breastconserving surgery Primary tumor 2 cm diameter , measure image Clinical Stage M0 WHO performance status â‰¤1 Adequate bone marrow , liver , renal function Multicentric invasive tumor Bilateral inflammatory breast cancer Receiving concomitant anticancer treatment chemotherapy Patients uncontrolled infection Patients concurrent severe and/or uncontrolled medical disease Additional protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Cancer Breast</keyword>
	<keyword>Neo-adjuvant</keyword>
	<keyword>Primary breast cancer</keyword>
	<keyword>postmenopausal</keyword>
	<keyword>pre-operative</keyword>
</DOC>